For example, by blocking the PD-1 signaling receptor, the tumor-specific CD8+ T lymphocytes in the tumor microenvironment (TME) restore cytotoxicity, thereby inhibiting tumor immune escape ability and controlling the disease. Here, PDCD1 is linked to neoplasm.